GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Albert David Ltd (BOM:524075) » Definitions » EV-to-FCF

Albert David (BOM:524075) EV-to-FCF : (As of Jun. 03, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Albert David EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Albert David's Enterprise Value is ₹3,734 Mil. Albert David's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil. Therefore, Albert David's EV-to-FCF for today is .

The historical rank and industry rank for Albert David's EV-to-FCF or its related term are showing as below:

BOM:524075' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 119.98
Current: 10.1

During the past 13 years, the highest EV-to-FCF of Albert David was 119.98. The lowest was 0.00. And the median was 0.00.

BOM:524075's EV-to-FCF is ranked better than
79.14% of 532 companies
in the Drug Manufacturers industry
Industry Median: 22.76 vs BOM:524075: 10.10

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-03), Albert David's stock price is ₹1156.00. Albert David's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹132.060. Therefore, Albert David's PE Ratio for today is 8.75.


Albert David EV-to-FCF Historical Data

The historical data trend for Albert David's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert David EV-to-FCF Chart

Albert David Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.51 1.94 4.58 17.85 9.46

Albert David Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.85 - - - 9.46

Competitive Comparison of Albert David's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Albert David's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert David's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Albert David's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Albert David's EV-to-FCF falls into.



Albert David EV-to-FCF Calculation

Albert David's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3733.599/0
=

Albert David's current Enterprise Value is ₹3,734 Mil.
Albert David's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albert David  (BOM:524075) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Albert David's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1156.00/132.060
=8.75

Albert David's share price for today is ₹1156.00.
Albert David's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹132.060.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Albert David EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Albert David's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert David (BOM:524075) Business Description

Traded in Other Exchanges
Address
8, Netaji Subhas Road, D-Block, 3rd Floor, Gillander House, Kolkata, WB, IND, 700001
Albert David Ltd is engaged in the manufacturing and trading of pharmaceutical products. The company offers products such as pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Its formulation product covers parenteral, oral, and enteral, topical agents, and vision care solutions. The company exports its product to regions like Latin America, South East Asia, and a few African countries.

Albert David (BOM:524075) Headlines

No Headlines